Selwyn P. Oskowitz, M.B.Ch.B.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fertilization in Vitro | 16 | 2019 | 1292 | 0.690 |
Why?
|
Embryo Disposition | 1 | 2019 | 14 | 0.680 |
Why?
|
Cryopreservation | 2 | 2019 | 717 | 0.480 |
Why?
|
Counseling | 1 | 2019 | 1541 | 0.380 |
Why?
|
Pregnancy, Ectopic | 2 | 2013 | 143 | 0.260 |
Why?
|
Embryo Transfer | 5 | 2013 | 522 | 0.250 |
Why?
|
Pregnancy, Multiple | 2 | 2000 | 215 | 0.180 |
Why?
|
Oocytes | 8 | 1996 | 1165 | 0.160 |
Why?
|
Ovulation Induction | 6 | 2003 | 277 | 0.150 |
Why?
|
Reproductive Techniques | 2 | 1995 | 41 | 0.150 |
Why?
|
Fertilization | 1 | 1996 | 197 | 0.130 |
Why?
|
Surgicenters | 1 | 1995 | 45 | 0.120 |
Why?
|
Gamete Intrafallopian Transfer | 6 | 1995 | 27 | 0.120 |
Why?
|
Uterine Perforation | 1 | 1993 | 4 | 0.110 |
Why?
|
Hysteroscopy | 1 | 1993 | 67 | 0.100 |
Why?
|
Uterine Rupture | 1 | 1993 | 67 | 0.100 |
Why?
|
Ovarian Follicle | 4 | 2003 | 244 | 0.100 |
Why?
|
Safety | 1 | 1995 | 1147 | 0.090 |
Why?
|
Progesterone | 3 | 1995 | 742 | 0.090 |
Why?
|
Torsion Abnormality | 1 | 2010 | 91 | 0.090 |
Why?
|
Clomiphene | 4 | 1991 | 71 | 0.080 |
Why?
|
Ovarian Diseases | 1 | 2010 | 137 | 0.080 |
Why?
|
Value of Life | 1 | 2008 | 98 | 0.080 |
Why?
|
Models, Econometric | 1 | 2008 | 216 | 0.070 |
Why?
|
Massachusetts | 1 | 2019 | 8823 | 0.070 |
Why?
|
Taxes | 1 | 2008 | 221 | 0.070 |
Why?
|
Fallopian Tubes | 2 | 1991 | 178 | 0.070 |
Why?
|
Luteal Phase | 1 | 1986 | 138 | 0.070 |
Why?
|
Technology Assessment, Biomedical | 1 | 2008 | 306 | 0.060 |
Why?
|
Chorionic Gonadotropin | 4 | 2003 | 457 | 0.060 |
Why?
|
Suction | 1 | 1986 | 262 | 0.060 |
Why?
|
Financing, Government | 1 | 2008 | 472 | 0.060 |
Why?
|
Gonadotropin-Releasing Hormone | 3 | 1999 | 1153 | 0.060 |
Why?
|
Pregnancy | 15 | 2013 | 29742 | 0.050 |
Why?
|
Salpingostomy | 1 | 2000 | 8 | 0.050 |
Why?
|
Chorionic Villi | 1 | 2000 | 53 | 0.050 |
Why?
|
Sterilization, Tubal | 1 | 1980 | 80 | 0.040 |
Why?
|
Infertility | 2 | 1999 | 655 | 0.040 |
Why?
|
Ovary | 3 | 2010 | 958 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 1993 | 2942 | 0.040 |
Why?
|
Pregnancy Outcome | 3 | 1996 | 2907 | 0.040 |
Why?
|
Menstrual Cycle | 3 | 1999 | 536 | 0.040 |
Why?
|
Follicle Stimulating Hormone | 5 | 2003 | 725 | 0.030 |
Why?
|
Health Policy | 1 | 2008 | 2677 | 0.030 |
Why?
|
Female | 27 | 2019 | 390323 | 0.030 |
Why?
|
Cytoplasmic Granules | 2 | 1996 | 573 | 0.030 |
Why?
|
Luteal Cells | 1 | 1995 | 19 | 0.030 |
Why?
|
Puberty, Delayed | 2 | 1987 | 121 | 0.030 |
Why?
|
Adult | 14 | 2019 | 219935 | 0.030 |
Why?
|
Health Care Costs | 1 | 2008 | 3245 | 0.030 |
Why?
|
Estradiol | 6 | 1999 | 1933 | 0.030 |
Why?
|
Granulosa Cells | 1 | 1995 | 115 | 0.030 |
Why?
|
Infertility, Female | 3 | 1991 | 759 | 0.030 |
Why?
|
Spermatozoa | 2 | 1996 | 631 | 0.030 |
Why?
|
Time Factors | 8 | 2013 | 39872 | 0.030 |
Why?
|
Abortion, Therapeutic | 1 | 1993 | 35 | 0.030 |
Why?
|
Leuprolide | 1 | 1995 | 314 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 1996 | 2557 | 0.030 |
Why?
|
Postoperative Complications | 2 | 1993 | 15637 | 0.020 |
Why?
|
Embryo Implantation | 1 | 2013 | 270 | 0.020 |
Why?
|
Placenta | 1 | 2000 | 1702 | 0.020 |
Why?
|
Uterus | 2 | 1993 | 651 | 0.020 |
Why?
|
Humans | 28 | 2019 | 758406 | 0.020 |
Why?
|
Pregnancy Trimester, Second | 1 | 1993 | 732 | 0.020 |
Why?
|
Menotropins | 4 | 1993 | 41 | 0.020 |
Why?
|
Benzimidazoles | 1 | 1994 | 855 | 0.020 |
Why?
|
Oocyte Retrieval | 1 | 2010 | 158 | 0.020 |
Why?
|
Accounting | 1 | 2008 | 25 | 0.020 |
Why?
|
Actuarial Analysis | 1 | 2008 | 374 | 0.020 |
Why?
|
Laparoscopy | 1 | 2000 | 2147 | 0.020 |
Why?
|
Diethylstilbestrol | 1 | 1988 | 88 | 0.020 |
Why?
|
Semen | 2 | 1993 | 346 | 0.020 |
Why?
|
Preimplantation Diagnosis | 1 | 2010 | 143 | 0.020 |
Why?
|
Meiosis | 1 | 2010 | 328 | 0.020 |
Why?
|
Cryoprotective Agents | 1 | 1989 | 128 | 0.020 |
Why?
|
Gonadotropins, Pituitary | 1 | 1987 | 69 | 0.020 |
Why?
|
Pituitary Hormone-Releasing Hormones | 1 | 1987 | 36 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 1993 | 1674 | 0.020 |
Why?
|
Federal Government | 1 | 2008 | 267 | 0.020 |
Why?
|
Prolactin | 2 | 1985 | 621 | 0.020 |
Why?
|
Luteinizing Hormone | 4 | 1995 | 820 | 0.020 |
Why?
|
Urticaria | 1 | 1987 | 150 | 0.020 |
Why?
|
Injections, Subcutaneous | 2 | 2003 | 677 | 0.020 |
Why?
|
Embryonic Development | 1 | 2010 | 716 | 0.020 |
Why?
|
Bromocriptine | 1 | 1984 | 93 | 0.010 |
Why?
|
Translocation, Genetic | 1 | 2010 | 1387 | 0.010 |
Why?
|
Amenorrhea | 1 | 1987 | 480 | 0.010 |
Why?
|
Follicular Fluid | 1 | 2003 | 92 | 0.010 |
Why?
|
Prospective Studies | 5 | 2003 | 54137 | 0.010 |
Why?
|
Employment | 1 | 2008 | 1112 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 2003 | 553 | 0.010 |
Why?
|
Life Expectancy | 1 | 2008 | 1244 | 0.010 |
Why?
|
Ultrasonography | 3 | 2010 | 5952 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9650 | 0.010 |
Why?
|
Fallopian Tube Diseases | 1 | 1980 | 60 | 0.010 |
Why?
|
Polycystic Ovary Syndrome | 1 | 1984 | 376 | 0.010 |
Why?
|
Hypogonadism | 1 | 1985 | 800 | 0.010 |
Why?
|
Fistula | 1 | 1980 | 214 | 0.010 |
Why?
|
Oogenesis | 1 | 1999 | 124 | 0.010 |
Why?
|
Drug Hypersensitivity | 1 | 1987 | 915 | 0.010 |
Why?
|
Testosterone | 1 | 1987 | 2471 | 0.010 |
Why?
|
Pregnancy Rate | 1 | 1999 | 649 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 1988 | 2496 | 0.010 |
Why?
|
Suture Techniques | 1 | 1980 | 788 | 0.010 |
Why?
|
Hospitalization | 1 | 1995 | 10652 | 0.010 |
Why?
|
Zona Pellucida | 1 | 1994 | 14 | 0.010 |
Why?
|
Sperm-Ovum Interactions | 1 | 1994 | 23 | 0.010 |
Why?
|
Incidence | 1 | 2013 | 21272 | 0.010 |
Why?
|
Aromatase | 1 | 1995 | 147 | 0.010 |
Why?
|
Follicular Phase | 1 | 1995 | 143 | 0.010 |
Why?
|
Insemination, Artificial | 1 | 1994 | 99 | 0.010 |
Why?
|
Age Factors | 3 | 1999 | 18358 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 23884 | 0.010 |
Why?
|
Male | 5 | 2010 | 358747 | 0.010 |
Why?
|
Cytoplasm | 1 | 1994 | 1514 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2013 | 80168 | 0.010 |
Why?
|
Microscopy | 1 | 1994 | 884 | 0.010 |
Why?
|
Laparotomy | 1 | 1991 | 465 | 0.010 |
Why?
|
Propylene Glycols | 1 | 1989 | 90 | 0.000 |
Why?
|
Pregnancy Maintenance | 1 | 1987 | 4 | 0.000 |
Why?
|
Dimethyl Sulfoxide | 1 | 1989 | 251 | 0.000 |
Why?
|
Cleavage Stage, Ovum | 1 | 1987 | 44 | 0.000 |
Why?
|
Organelles | 1 | 1989 | 267 | 0.000 |
Why?
|
Fluorescent Dyes | 1 | 1994 | 1897 | 0.000 |
Why?
|
Child, Preschool | 1 | 2008 | 42062 | 0.000 |
Why?
|
Adolescent | 3 | 2008 | 87892 | 0.000 |
Why?
|
Sperm Count | 1 | 1985 | 228 | 0.000 |
Why?
|
Ultrasonics | 1 | 1985 | 206 | 0.000 |
Why?
|
Anovulation | 1 | 1984 | 54 | 0.000 |
Why?
|
Logistic Models | 1 | 1999 | 13276 | 0.000 |
Why?
|
Sperm Motility | 1 | 1985 | 265 | 0.000 |
Why?
|
Ovulation | 1 | 1984 | 181 | 0.000 |
Why?
|
Dehydroepiandrosterone | 1 | 1984 | 257 | 0.000 |
Why?
|
Olfaction Disorders | 1 | 1985 | 224 | 0.000 |
Why?
|
Chromatin | 1 | 1994 | 2938 | 0.000 |
Why?
|
Antibody Formation | 1 | 1987 | 1400 | 0.000 |
Why?
|
DNA | 1 | 1994 | 7199 | 0.000 |
Why?
|
United States | 1 | 2008 | 72136 | 0.000 |
Why?
|
Child | 1 | 2008 | 79818 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1995 | 18940 | 0.000 |
Why?
|
Syndrome | 1 | 1985 | 3262 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1980 | 39059 | 0.000 |
Why?
|
Drug Administration Schedule | 1 | 1985 | 4839 | 0.000 |
Why?
|
Case-Control Studies | 1 | 1995 | 22029 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1987 | 4540 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1985 | 10748 | 0.000 |
Why?
|
Treatment Outcome | 1 | 1999 | 64378 | 0.000 |
Why?
|
Mice | 1 | 1989 | 81101 | 0.000 |
Why?
|
Animals | 1 | 1989 | 167768 | 0.000 |
Why?
|
Middle Aged | 1 | 1991 | 219568 | 0.000 |
Why?
|